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Introduction 
  
elioidosis is an infectious disease 
caused by saprophytic gram negative 
bacillus, Burkholderia pseudomallei. It is an 
important public health problem in 
Southeast Asia and northern Australia. It 
has been increasingly recognized as an 
important cause of sepsis in humans and  
animals in this region. The infection is 
acquired usually either through inhalation 
of aerosolized B. pseudomallei or direct 
inoculation.  
The causative organism, Burkholderia 
pseudomallei, was previously known as 
Pseudomonas pseudomallei. During the last 
century this gram-negative environmental 
bacterium has been variously known as
M 
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Bacillus pseudomallei, Bacillus whitmorii 
(or Bacille de Whitmore), Malleomyces  
pseudomallei, Pseudomonas pseudomallei.  
In 1992, Yabuuchi et al1. proposed to assign 
this group to genus Burkholderia as 
reported by Dance et al2. The genus 
Burkholderia now contains more than 20 
validly named species, most of which have 
been isolated from soil and water.  
This potentially lethal disease affecting man 
and animal by direct inoculation or 
inhalation of infectious particles is an 
important cause of acute pneumonia. 
However, the clinical manifestations diverse 
from indolent skin ulcers to visceral 
abscesses, pneumonia, and irresistible 
septicaemia3. 
At present, it is still difficult to deferentiate 
the septicemia caused by B. pseudomallei 
from other organisms. Thus, laboratory 
diagnosis is very important to ensure the 
successful diagnosis and patient 
management. Currently, bacterial culture is 
accepted as the ‘Gold Standard Method’ in 
many hospitals in Malaysia. Immunological 
and molecular techniques, e.g. 
serodiagnosis, PCR, have been developed 
but still cannot yet replace the time 
consuming culture method. 
Thus, the aim of the current study is to 
assess and compare the culture, biochemical 
profile, serology and molecular status of this 
potential bacterium.  
 
Materials and Methods 
  
Collection of Specimens 
 A total of 32 strains of B. pseudomallei were 
isolated from specimens collected from the 
patients admitted to Hospital Tengku 
Ampuan Afzan (HTAA), Kuantan, Malaysia 
during the period from 1st January 2007 
until 30th March 2008.  Three environmental 
strains were kindly provided by the 
Institute for Medical Research (IMR), Kuala 
Lumpur. 
    
Bacterial culture 
Pus, wound swabs, and blood specimens 
were cultured on Blood agar, Mac Conkey, 
and Francis media.  Plates were incubated at 
37˚C for 24 hours. Colonies observed on 
these agar plates were identified by their 
biochemical profile as well as by 
morphological features. 
 
Preparation of media 
 Preparation of Blood Agar (BA), Mac 
Conkey and Mueller Hinton agar according 
to the instruction of the manufacturer 
(OXOID). 
  
Preparation of Francis agar 
 Twelve grams of nutrient agar powder was 
dissolved in 500 ml deionized water and 20 
ml of glycerol was added. Aq crystal violet 
(2.5ml) and Aq bromocresol purple (15ml) 
was added to the mixture. Gentamicin (8 
μg/ml) was added after autoclaving at 
121°C for 15 minutes. 
  
Biochemical tests 
 Oxidase activity, catalase activity, indole 
test, triple sugar iron agar (TSI), motility 
test, citrate test, urea test, tests for acid from 
carbohydrates, gelatine hydrolysis were 
performed according to the manual4. 
 
Serology procedure 
i. Indirect Immunofluorescent antibody 
test (IFAT) 
This test was performed on 32 
confirmed cases of melioidosis.  
Collected sera were stored in a -20°C 
freezer until testing. IFAT test was done 
to investigate the level of antibody. The 
test procedure was divided into two 
parts: 
a. The preparation of the antigen.  
b. The test proper. 
  
ii. Preparation of antigen 
 Strains of B. pseudomallei were 
subcultured from nutrient agar (NA) to 
blood agar.  On the next day, one 
quadrant of the growth was scraped and 
transferred to tubes of 4 ml Trypticase 
Soy Broth (TSB). Then, it was vortexed 
vigorously and the solution was 
incubated overnight at 37˚C. 
On the following day, the antigen was 
boiled using double boiling technique. 
The Ag solutions were then spun at 3000 
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rpm for 15 minutes (3x). The 
supernatant was discarded, and the 
pellet was washed. Finally, the prepared 
Ag suspension was diluted with PBS, 
pH 7.3 and the turbidity was adjusted to 
0.5 McFarland standard. 
Coating of slides with the prepared 
antigen. 
Twelve wells teflon glass microscope 
slides were cleaned by rinsing with 75% 
ethanol. Each test well was filled with 20 
μl of the prepared antigen; air dried and 
fixed with cold acetone. The coated 
slides were dried in a laminar flow 
hood, labelled properly and kept at – 20 
˚C prior to usage5. 
 
iii. The screening test 
 Serial double dilutions of patients’ sera 
were made with PBS buffer and 
dispensed in the tested area. The slides 
were then incubated in a modified moist 
chamber at 37°C for 30 minutes and 
then washed with PBS buffer at pH 7.4 
for 10 minutes, and left to dry. 
Fluorescein-conjugated anti-human 
serum was added to each test well5. 
After incubation, slides were washed 
with PBS buffer.  The slides were 
mounted with mixture of glycerol: PBS 
buffer in ratio of 9: 1. The slides were 
screened under Zeiss UV microscope. A 
titre of 1: 80 was suggestive of 
melioidosis.  
 
iv. Molecular identification  
All isolates were examined for the 
presence of the LPS virulence gene by 
PCR.  Earlier, bacterial DNA was 
extracted from both pure colonies and 
also directly from the clinical specimens.  
The Master Pure DNA and RNA 
extraction kit (Epicentre Technology, 
USA) was used for this purpose.  All 
extracted DNAs were kept in TAE 
buffer at -20°C until PCR was done. 
 
 
 
 
v. Primers 
Primers used in this technique were 
derived from the lipopolysaharide (LPS) 
gene sequence of the bacteria as 
described by Wongratanacheewin and 
his co-workers6. Forward primer 
sequence: LPS1  5-CTCTCA-
GATTGCTGACAAACCC-3  and  
reverse: LPS2 primer: 5-CGGATGA-
ACTCGAAATCCACCG-3.     
  
vi. PCR mixtures 
The main components of PCR mixtures 
were calculated with according to 
Narisara et. al7.  PCR was performed 
with a GeneAmp PCR system 9700 (PE 
Applied Biosystem, Norwalk, 
Connecticut).  PCR condition was:  
denaturation at 94°C for 5 min, 
amplification at 94°C for 30 sec, 
annealing 65°C for 30 sec,  and 
extension at 72°C for 45 sec. A total of 35 
cycles were carried out. 
  
vii. Visualization of PCR band 
Amplified products were then analysed 
by gel electrophoresis system.  The gel 
was stained with ethidium bromide for 
10 seconds. It was rinsed with tap water 
andwas visualized under BIO-RAD UV 
transilluminator 2000.  The photograph 
of the results was taken and the bands 
were analyzed. 
Results 
   
Growth on blood agar  
 On blood agar, twenty-seven isolates from 
32 clinical specimens produced whitish, 
small (3-5mm), smooth creamy mucoid 
colonies in the first 1 to 2 days of incubation 
at 37o C (Figure 1).  Thirty strains exhibited 
beta-homolysis while the others were non-
haemolytic.  Colonies of the three 
environmental strains were less mucoid 
when compared to the clinical isolates. 
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Figure 1.  Beta-haemolytic colonies on blood 
agar plate. 
 
Growth on MacConkey Agar 
Bacterial growth on MacConkey medium 
was visible after 24h of incubation at 37°C.  
Thirty-one out of 35 isolates produced 
pinkish colonies with a metallic sheen 
(Figure 2).  
 
Figure 2.  Colonies showed a metallic sheen on 
MacConkey agar plate. 
 
Growth on Francis Medium 
All 35 isolates grew well on this medium 
producing lush growth after 18 hours 
incubation at 37o C.  The growth showed a 
yellow haze along with the primary streak 
lines (Figure 3).  Within 24 hours the yellow 
haze on the medium extended to the 
secondary streak lines.  This yellow 
colouration was found to be unique to B. 
pseudomallei colonies isolated in other part 
of Malaysia8. A very pronounced, distinctive 
earthy odour was also noted. 
 
 
Figure 3.   B. pseudomallei produced a yellow 
haze along the primary streak lines. 
 
Gram staining 
Twenty-seven clinical isolates of B. 
pseudomallei showed small, straight gram-
negative rods while the others exhibited 
slightly curved appearance.  Characteristic 
bipolar morphology of the organism mimics 
a "safety pin" like appearance (Figure 4).  
The organisms are seen singly, in pairs or 
very occasionally in chains.  They measured 
about 2 – 5μm in length and 0.4–0.8μm in 
diameter. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Gram stain of B. pseudomallei (100x). 
 
Biochemical reactions of the strains 
 Organisms were motile; catalase and 
oxidase positive. The results of the reactions 
towards carbohydrates are summarized in 
Table 1.  
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Table 1: Activities of B. pseudomallei towards carbohydrates (number of strain tested). 
 Clinical isolates from Environmental 
 Blood (28) Urine, Pus, Body fluid (4) Isolates (3) 
Pentoses    
 D-arabinose + + - 
L-arabinose + +2 + 
    
Hexoses    
Glucose + + + 
Glucose Gas +27 + + 
Fructose + + + 
Mannitol + + + 
Disaccharides     
Lactose + + + 
Maltose + + + 
Sucrose + + + 
+: Positive,    - : Negative   
 
 
Table 2. Activities of B. pseudomallei towards amino acids and proteins 
 Clinical isolates from Environmental 
 Blood (28) Urine, Pus, Body fluid (4) Isolates (3) 
Amino acids   - 
Arginine dihydrolase + + + 
Lysine decarboxylase - - - 
Ornithine decarboxylase - - - 
Tryptophane deaminase 
(Indole) 
- - - 
      
Proteins    
Gelatine liquefaction + + + 
Hydrolysis     
Citrate + + + 
Urea - - - 
+: Positive,    - : Negative   
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178bp
M     2    3    4   5    6   M 
250bp250bp
200bp
IFAT test  
Thirty sera specimen  showed positive as the 
cut-off positive titre was considered  to be ≥ 
1/ 80. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Positive serum sample as identified by 
IFAT test.  
 
PCR 
LPS genes were detected from 30 out of 32 
clinical isolates.  The amplified band size 
was 178 bp. 
 
 
 
 
 
 
 
 
 
 
 
  Figure 6.   Ethidium bromide-stained PCR. 
 
products on a 2% agarose gel.  Lane M: 
DNA size markers.  Lane 2,4,6: B. 
pseudomallei positive tested isolates.  PCR 
products from clinical isolates of B. 
pseudomallei were identified at 178bp.  No 
specific amplifications were seen for S. 
pneumoniae (3) and P. aeruginosa (5). 
  
 
 
Discussion 
  
The crucial need to make correct early 
diagnose in cases of melioidosis has always 
been problematic and is a dilemma for both 
clinicians as well as the laboratory 
pathologists.  To date, this still relies on 
isolation and accurate identification of the 
pathogen from clinical specimens.  Culture 
is considered as the gold standard even 
though a delay of 24 to 48h or more between 
the time of specimen plating and 
presumptive bacterial identification.  
Phenotypic identification of Burkholderia 
pseudomallei is often delayed if laboratory 
personnel are still unfamiliar with the 
bacterium and may overlook it as 
Pseudomonas sp. Several other serologic 
and molecular methods have been tested, 
but not yet thoroughly clinically evaluated.   
In this study, we successfully identified 35 
isolates (32 clinical, and three 
environmental).  The isolation rate was 
higher with the use of Francis medium. 
Initially, we cultured the samples and 
evaluated the characteristics of the isolates 
on three different media, blood agar, Mac 
Conkey agar, and Francis agar.  Growth on 
blood agar revealed beta-haemolysis in most 
of the clinical strains but all environmental 
strains were alpha-haemolytic. Observation 
on Mac Conkey agar showed reddish 
colonies probably because of oxalic acid 
production from amino acids rather than 
fermentation of lactose as described by 
Gilligan et al9. 
On Francis medium, B. pseudomallei grew 
rapidly producing colonies with a yellow 
haze along the primary streak lines after 18 
hours of incubation.  This rapid growth rate 
differentiates the organism from B. mallei, 
which typically takes a minimum of 72 
hours to grow.  This medium can be 
considered as both a selective and 
differential one.  Mac Conkey medium is a 
selective one while blood agar acts as a 
differential medium only.  In clinical 
specimens like pus which is generally 
heavily contaminated by other organisms, B. 
pseudomallei can be overgrown along with 
contaminating flora. But the generation time 
for B. pseudomallei is considerably longer 
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than that of other common bacteria.  Thus, 
selective inhibition of other organisms is 
essential for the recovery of B. pseudomallei. 
Our results are in accord with these of 
Francis et al which confirmed that the use of 
Francis medium enables the hospital 
microbiologists to give an early preliminary 
diagnosis of melioidosis within 24 hrs of 
receiving a clinical specimen8. We also 
found that the medium is easy to prepare 
from readily obtainable materials at low 
cost.  However, some training and 
experience is needed to read the plates.  In 
spite of this improvement in culture 
technique, most studies showed that culture 
dependent diagnostic procedures give 
delayed results that are obtained too late to 
influence clinical management9-11.  
Biochemical tests are still needed to confirm 
the diagnosis and this will approximately 
lead to additional 1-2 days of processing 
time.  Conventional biochemical tests and 
API20E substrate-utilization test panel 
[bioMιrieux] kit commonly is used for 
identification of B. pseudomallei can easily 
misidentify the organism 
as Chromobacterium violaceum12.  This is 
the point where the vital part of this study 
comes in. 
We aimed at diagnosis of melioidosis by 
culture and characterized the isolates 
biochemically and molecularly by PCR. This 
standard diagnostic method was then 
compared with sero-diagnosis by IFAT and 
direct detection by LPS-PCR.  
Various techniques have been applied as 
complimentary diagnostic tools beside 
culture.  A frequently employed test is 
serology, looking for specific antibodies.  
Serology is useful to monitor disease activity 
and relapse.  Early serological tests 
developed by Nigg were the complement 
fixation test and the haemagglutination test 
(IHAT) using crude extracts of B. 
pseudomallei as antigen. Strauss et al13,14.  
did a seroprevalence study by the IHAT 
using an antigen from cultured supernatant 
termed melioidin.  Their findings indicated 
widespread occurrence of antibodies to B. 
pseudomallei in the human population 
living in endemic areas (ranging from 2-
16%).  A study in north-eastern Thailand has 
shown the indirect haemagglutination test 
(IHA) to have a sensitivity of 95% but a 
specificity of only 59% by using a cut-off 
titre of 1:20.  In that study, some of the non-
melioidosis septicaemia patients had 
positive titres of more than 1:1,280. This 
high antibody titre may persist for a long 
time after the infection subsides.  However, 
acute seroconversion in a clinically septic 
patient from endemic areas strongly 
suggests melioidosis.   
Latex agglutination with a monoclonal 
antibody specific for the extracellular 
polysaccharide of B. pseudomallei has the 
advantage of avoiding cross-reactivity with 
B. thailandensis15,16.  However, since the 
latter species is rarely isolated from clinical 
cases of melioidosis, it has not been fully 
characterized17.   
A form of indirect fluorescent antibody 
technique (IFAT) was initiated by Ashdown 
to develop an IgG and IgM 
immunofoluerescent test for melioidosis.  
Thus, the second phase of our study was to 
revise and evaluate the IFAT serodiagnostic 
tool5.  The technique involves formation of 
an antigen-antibody complex detected by 
fluorescein-conjugated anti-human 
immunoglobulin antibody.  Though 
immunoflurorescent antibody assay is said 
to be rapid, highly sensitive and specific test 
for the diagnosis of infection, it requires a 
fluorescent microscope that is not always 
available in some remote laboratories in 
endemic areas. 
A study done by Vadivelu et al18. suggested 
that the IFAT was practical in monitoring 
the progression of the disease during 
maintenance therapy since patients with 
localized non-septicaemic infections and on 
maintenance therapy demonstrated 
progressive reduction in titters.  Moreover, 
these findings also demonstrate the need to 
follow-up patients with melioidosis, even 
though they are clinically asymptomatic, 
there is serologic evidence that the infection 
has resolved.  In addition in a healthy 
immunocompetent, young individual given 
appropriate therapy at an early stage, it may 
be possible to overcome the long-term 
survival of the bacterium in vivo. IFAT is  
Relatively labour intensive and takes more  
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than 2h to complete.   
The PCR assay can be completed within 1 
day, whereas cultures for B. pseudomallei 
typically require up to 5 days for 
identification of the bacteria.  In addition to 
diagnostic applications, nucleic acid 
amplification procedures can also be 
modified as in real time PCR to allow for the 
quantitative measurement of bacterial load 
in order to monitor response to antibiotic 
therapy. 
Thus, our report managed to exemplify the 
usefulness of PCR-mediated typing of B. 
pseudomallei from a clinical perspective.  
Additional evaluation is required in other 
locations where melioidosis is endemic, with 
testing of samples from multiple tissue sites 
in parallel with culture.   
 
Conclusion  
 It has been demonstrated that B. 
pseudomallei culture characteristic varies 
between strains and culture media.  The 
false impression of mixed culture can be 
made due to variable colony morphology 
that is often seen in a single isolate.  Francis 
medium showed the best result for the 
isolation of the organism. The IFAT 
serological test successfully quantified 
antibody at the initial time of admission but 
was not able to define disease activity and 
differentiate an acute infection from a 
previous one or relapse. Further study needs 
to be done to modify and improve this 
valuable technique in order to shorten the 
diagnostic time-length and increase its 
sensitivity.  Despite the pros and cons in the 
method, the IFAT method may be very 
useful for prognostic purposes and 
maintenance therapy.  
In addition, the usefulness of PCR-mediated 
detection and identification of B. 
pseudomallei in clinical settings is 
highlighted.  We suggest that the LPS-PCR 
system can be applied not only for blood 
specimen, but to be extended to other 
clinical specimens such as sputum, urine, 
cerebrospinal fluid as a complement to 
culture. 
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